knowledge -WSS

knowledge

author：fashion 2025-09-27 09:58:26 - browse：2

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Listen: Who gets the credit for GLP

knowledge

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: XBI biotech index, Akero Therapeutics

How one patient went off dialysis — and others can too

Listen: Who gets the credit for GLP

Researchers use wearables data and AI to predict preterm birth risk

Wikipedia

knowledge

hotspot

Continuity nursing helped my family in our darkest PICU moments

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Testing for cancer recurrence creates a new limbo for patients

How to save PrEP access — and even expand it

Listen: Who gets the credit for GLP

The cancer drug shortage isn’t new — and neither are the solutions

First Opinion Podcast: How to protect health care in times of war

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Maker of FluMist seeks to allow at

Wikipedia

Paxlovid should be available without a positive Covid test

Biden's order seeks to regulate AI risk without stifling innovation

Cassava reveals details — and problems — with Alzheimer's study

Address the ethical violations that led to 'Three Identical Strangers'

Physician subsidies by hospitals soar in wake of No Surprises Act

Listen: Who gets the credit for GLP

explore

hotspot

knowledge

explore